- Jan 27, 2002
- 5,385
- 0
- 71
Not what the article is really about but once again human life takes a backseat to the almighty dollar.
http://www.msnbc.msn.com/id/37576973/ns/disaster_in_the_gulf/?gt1=43001
About 70 percent of Louisiana hospitals have enough antidote to treat one serious bite, or about 12 vials, Ryan said. That doesnt count injuries from the rare but dangerous coral snake, however. The cure for that critters venom has been in short supply ever since the drugs longtime manufacturer, Wyeth Pharm., decided to pull the plug on the low-profit product.
We have six vials left in the state, Ryan said. Its almost to a critical point right now.
Pfizer Inc., which bought Wyeth last year, has no plans to start making North American Coral Snake Antivenin again. A Mexican drug manufacturer makes an anti-venom, called Coralmyn, but it is not licensed by the U.S. Food and Drug Administration.
Remaining coral snake anti-venom supplies are set to expire in October, although the FDA could extend the shelf life. Once its all expired or used, coral snake victims will have to take their chances on surviving the venom, which paralyzes nerves and muscles, causing respiratory distress and, sometimes, death.
http://www.msnbc.msn.com/id/37576973/ns/disaster_in_the_gulf/?gt1=43001